Cargando…
The Bri2 and Bri3 BRICHOS Domains Interact Differently with Aβ(42) and Alzheimer Amyloid Plaques
Alzheimer’s disease (AD) is the most common form of dementia and there is no successful treatment available. Evidence suggests that fibril formation of the amyloid β-peptide (Aβ) is a major underlying cause of AD, and treatment strategies that reduce the toxic effects of Aβ amyloid are sought for. T...
Autores principales: | Dolfe, Lisa, Tambaro, Simone, Tigro, Helene, Del Campo, Marta, Hoozemans, Jeroen J.M., Wiehager, Birgitta, Graff, Caroline, Winblad, Bengt, Ankarcrona, Maria, Kaldmäe, Margit, Teunissen, Charlotte E., Rönnbäck, Annica, Johansson, Jan, Presto, Jenny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159705/ https://www.ncbi.nlm.nih.gov/pubmed/30480246 http://dx.doi.org/10.3233/ADR-170051 |
Ejemplares similares
-
Recombinant Bri3 BRICHOS domain is a molecular chaperone with effect against amyloid formation and non-fibrillar protein aggregation
por: Poska, Helen, et al.
Publicado: (2020) -
Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state
por: Chen, Gefei, et al.
Publicado: (2017) -
Functionalization of amyloid fibrils via the Bri2 BRICHOS domain
por: Biverstål, Henrik, et al.
Publicado: (2020) -
BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells
por: Oskarsson, Marie E., et al.
Publicado: (2018) -
The best of SBP-BRiMS
por: Carley, Kathleen M.
Publicado: (2020)